247 related articles for article (PubMed ID: 23890461)
41. Irritable bowel syndrome patients' perspectives on their relationships with healthcare providers.
Halpert A; Godena E
Scand J Gastroenterol; 2011 Jul; 46(7-8):823-30. PubMed ID: 21561228
[TBL] [Abstract][Full Text] [Related]
42. Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease.
Peters SL; Muir JG; Gibson PR
Aliment Pharmacol Ther; 2015 Jun; 41(11):1104-15. PubMed ID: 25858661
[TBL] [Abstract][Full Text] [Related]
43. Effect of Hypnotism on the Severity of Gastrointestinal Symptoms and Quality of Life in Individuals With Irritable Bowel Syndrome.
Mohebbi Z; Firoozabadi A; Naini MA; Sharif F; Keshtkaran Z; Heydari N
J Psychosoc Nurs Ment Health Serv; 2022 May; 60(5):55-62. PubMed ID: 34677120
[TBL] [Abstract][Full Text] [Related]
44. Review article: the effectiveness of group and self-help hypnotherapy for irritable bowel syndrome and the implications for improving patients' choice and access to treatment.
Gillan C
Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1389-1404. PubMed ID: 34591988
[TBL] [Abstract][Full Text] [Related]
45. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.
Devenney J; Hasan SS; Morris J; Whorwell PJ; Vasant DH
Aliment Pharmacol Ther; 2024 Jan; 59(2):269-277. PubMed ID: 37927144
[TBL] [Abstract][Full Text] [Related]
46. Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action.
Tan G; Hammond DC; Joseph G
Am J Clin Hypn; 2005 Jan; 47(3):161-78. PubMed ID: 15754863
[TBL] [Abstract][Full Text] [Related]
47. Perceptions of gastroenterologists and nurses regarding irritable bowel syndrome and inflammatory bowel disease.
Dickman R; Segev M; Levi S; Reicher-Atir R; Steinmetz A; Horev N; Niv Y
Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):813-7. PubMed ID: 21701390
[TBL] [Abstract][Full Text] [Related]
48. No change in rectal sensitivity after gut-directed hypnotherapy in children with functional abdominal pain or irritable bowel syndrome.
Vlieger AM; van den Berg MM; Menko-Frankenhuis C; Bongers ME; Tromp E; Benninga MA
Am J Gastroenterol; 2010 Jan; 105(1):213-8. PubMed ID: 19861956
[TBL] [Abstract][Full Text] [Related]
49. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients.
Miller V; Carruthers HR; Morris J; Hasan SS; Archbold S; Whorwell PJ
Aliment Pharmacol Ther; 2015 May; 41(9):844-55. PubMed ID: 25736234
[TBL] [Abstract][Full Text] [Related]
50. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
[TBL] [Abstract][Full Text] [Related]
51. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
Jones MP; Bratten J; Keefer L
Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
[TBL] [Abstract][Full Text] [Related]
52. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
[TBL] [Abstract][Full Text] [Related]
53. The benefits of a nurse-led service in the identification and management of symptoms of irritable bowel syndrome.
Moore JS; Gagan MJ; Perry RE
Gastroenterol Nurs; 2014; 37(6):416-23. PubMed ID: 25461463
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial.
Flik CE; Laan W; Zuithoff NPA; van Rood YR; Smout AJPM; Weusten BLAM; Whorwell PJ; de Wit NJ
Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):20-31. PubMed ID: 30473202
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
Cremonini F; Talley NJ
Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518
[TBL] [Abstract][Full Text] [Related]
56. Hypnotherapy for irritable bowel syndrome: the response of colonic and noncolonic symptoms.
Whorwell PJ
J Psychosom Res; 2008 Jun; 64(6):621-3. PubMed ID: 18501263
[TBL] [Abstract][Full Text] [Related]
57. Management of irritable bowel syndrome (IBS) in adults: conventional and complementary/alternative approaches.
Yoon SL; Grundmann O; Koepp L; Farrell L
Altern Med Rev; 2011 Jun; 16(2):134-51. PubMed ID: 21649455
[TBL] [Abstract][Full Text] [Related]
58. Complementary and alternative medicines in irritable bowel syndrome: an integrative view.
Grundmann O; Yoon SL
World J Gastroenterol; 2014 Jan; 20(2):346-62. PubMed ID: 24574705
[TBL] [Abstract][Full Text] [Related]
59. A comparison of irritable bowel syndrome patients managed in primary and secondary care: the Episode IBS study.
Smith GD; Steinke DT; Kinnear M; Penny KI; Pathmanathan N; Penman ID;
Br J Gen Pract; 2004 Jul; 54(504):503-7. PubMed ID: 15239911
[TBL] [Abstract][Full Text] [Related]
60. Why do subjects with irritable bowel syndrome seek health care for their symptoms?
Ringström G; Abrahamsson H; Strid H; Simrén M
Scand J Gastroenterol; 2007 Oct; 42(10):1194-203. PubMed ID: 17852851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
